Hexahydrocannabinol (HHC) and Δ9-tetrahydrocannabinol (Δ9-THC) driven activation of cannabinoid receptor 1 results in biased intracellular signaling
Scientific Reports April 22, 2024 Oleh Durydivka, Petr Palivec, Matej Gazdarica et al. 7 citations
Hexahydrocannabinol (HHC) activates cannabinoid receptor 1 (CB1R) in ways only broadly comparable to Δ9-tetrahydrocannabinol (Δ9-THC), with each HHC epimer showing unique signaling properties. HHC's greater chemical stability than Δ9-THC makes it a potential candidate for modern medicine. The study examined the pharmacodynamics of HHC epimers and their activation of CB1R-mediated signaling pathways, comparing them to those activated by Δ9-THC.